US Morning News Call | Trump Raises Global Tariffs to 15% From 10% After Supreme Court Loss

🔔Before the Bell

U.S. stock futures declined on Monday after President Donald Trump announced he would raise his global tariffs to 15% from 10%, following a Supreme Court decision that struck down his “reciprocal” tariffs.

$E-mini NASDAQ 100 Futures (MAR6) (NQmain.US)$ went down by 0.62%;

$E-mini S&P 500 Futures (MAR6) (ESmain.US)$ went down by 0.41%;

$E-mini Dow Futures (MAR6) (YMmain.US)$ went down by 0.37%.

Trump Raises Global Tariffs to 15% After Supreme Court Loss

Trump increased new global tariffs from 10% to 15%. Mexico and Canada remain exempt from the tariff under USMCA compliance terms, maintaining their status as top US trading partners.

Supreme Court Strikes Down Trump's Global Tariffs in 6-3 Decision

The Supreme Court struck down President Trump's global tariffs in a 6-3 ruling, finding he exceeded his authority using the International Emergency Economic Powers Act. The decision voided baseline 10% tariffs on virtually every country and steeper levies on other nations.

US CBP to Halt Collections of Trump’s IEEPA Tariffs After Supreme Court Ruling

US Customs and Border Protection said it will stop collecting tariffs imposed under President Trump’s IEEPA-based orders starting 12:01 a.m. EST Tuesday and will deactivate the related tariff codes.

Fed Officials Signal Cautious Stance on Rate Cuts as Warsh Awaits Confirmation

Federal Reserve meeting minutes reveal broad agreement to hold rates at 3.50%-3.75% amid hawkish sentiment. Officials noted moderated employment risks but persistent inflation concerns. Several preferred keeping rate hikes explicitly available if inflation stays elevated.

Nvidia Plans Return to Consumer PC Market with AI Laptop Chips in 2026

NVIDIA (NVDA.US) plans to return to the consumer PC market with AI laptop chips hitting the market in 2026. Dell Technologies, Lenovo and other PC makers are working with Nvidia on models using Nvidia-MediaTek system-on-a-chip built on Arm architecture.

Novo Nordisk's CagriSema Weight-Loss Drug Fails to Meet Primary Trial Endpoint

Novo-Nordisk A/S (NVO.US) 's weight-loss treatment CagriSema failed to demonstrate non-inferiority to Eli Lilly's tirzepatide in a late-stage trial. CagriSema achieved 23% weight reduction versus tirzepatide's 25.5% over 84 weeks. Eli Lilly and Co (LLY.US)

Apple Eyes Visual Artificial Intelligence

Reports suggest Apple (AAPL.US) is developing a new wearable form factor—potentially an AI pin/pendant—and exploring AirPods with cameras, aligning with CEO Tim Cook’s recent emphasis on Visual Intelligence. Apple is also working to replace the current ChatGPT handoff with its own in-house visual models for image-based queries.

🪙Crypto News

Bitcoin (BTC.CC) fell -1.86% to 66381.73;Ethereum (ETH.CC) fell -2.01% to 1918.52.

Stablecoins Could Generate Up to $1T in New T-Bill Demand

Standard Chartered forecasts the stablecoin market cap will reach $2 trillion by the end of 2028, driving roughly $0.8–$1 trillion of fresh demand for short-term U.S. Treasury bills as issuers hold T-bills as reserves under the GENIUS Act. The bank argues this could make bills scarce and give the Treasury room to tilt issuance toward the front end—potentially even pausing 30-year bond auctions for up to three years if demand materializes.

📆Market Events

Key Results

🔔After Market

The market anticipates Hims & Hers Health (HIMS.US) revenue of $617 million, up 28.29% YOY, with net income at $10.5 million, a 59.57% YOY decrease.